Amedeo Smart

Free Medical Literature Service



Bladder Cancer

  Free Subscription


1 Actas Urol Esp
1 Anticancer Res
1 Biochem Biophys Res Commun
1 Biomark Res
1 Biomed Pharmacother
1 Can J Urol
1 Carcinogenesis
1 Curr Opin Urol
2 Exp Ther Med
1 Expert Opin Pharmacother
1 Hum Exp Toxicol
3 Hum Pathol
1 IDCases
1 Int J Med Robot
1 Int J Mol Sci
1 Int Urol Nephrol
1 J Natl Compr Canc Netw
1 J Urol
1 Lakartidningen
1 Medicine (Baltimore)
3 Oncol Rep
8 Oncotarget
3 PLoS One
1 Res Rep Urol
2 World J Urol

    Actas Urol Esp

  1. LLORENTE C, Lopez B, Hernandez V, Guijarro A, et al
    Variability in complications and operative mortality after radical cystectomy in Spain.
    Actas Urol Esp. 2017;41:32-38.
    >> Share

    Anticancer Res

  2. D'ANDREA D, Moschini M, Soria F, Gust KM, et al
    ABO Blood Group and Rhesus Factor Are Not Associated with Outcomes After Radical Cystectomy for Non-metastatic Urothelial Carcinoma of the Bladder.
    Anticancer Res. 2017;37:5747-5753.
    >> Share

    Biochem Biophys Res Commun

  3. LIU D, Qiu XY, Wu X, Hu DX, et al
    Piperlongumine suppresses bladder cancer invasion via inhibiting epithelial mesenchymal transition and F-actin reorganization.
    Biochem Biophys Res Commun. 2017 Oct 13. pii: S0006-291X(17)32039.
    >> Share

    Biomark Res

  4. NAKAGAWA M, Karashima T, Kamada M, Yoshida E, et al
    Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-gamma2 as a promising diagnostic tool of non-muscle invasive bladder cancer.
    Biomark Res. 2017;5:29.
    >> Share

    Biomed Pharmacother

  5. SALEHI S, Mansoori B, Mohammadi A, Davoudian S, et al
    An analysis of suppressing migratory effect on human urinary bladder cancer cell line by silencing of snail-1.
    Biomed Pharmacother. 2017;96:545-550.
    >> Share

    Can J Urol

  6. GOMELLA LG, Mann MJ, Cleary RC, Hubosky SG, et al
    Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.
    Can J Urol. 2017;24:8620-8626.
    >> Share


  7. SELINSKI S, Blaszkewicz M, Ickstadt K, Gerullis H, et al
    Identification and replication of the interplay of four genetic high risk variants for urinary bladder cancer.
    Carcinogenesis. 2017 Sep 27. doi: 10.1093.
    >> Share

    Curr Opin Urol

  8. MARI A, Abufaraj M, Gust KM, Shariat SF, et al
    Novel endoscopic visualization techniques for bladder cancer detection: a review of the contemporary literature.
    Curr Opin Urol. 2017 Oct 17. doi: 10.1097/MOU.0000000000000459.
    >> Share

    Exp Ther Med

  9. FENG C, Ho Y, Sun C, Xia G, et al
    Epigallocatechin gallate inhibits the growth and promotes the apoptosis of bladder cancer cells.
    Exp Ther Med. 2017;14:3513-3518.
    >> Share

  10. ZHANG B, Wu Z, Xie W, Tian D, et al
    The expression of vasohibin-1 and its prognostic significance in bladder cancer.
    Exp Ther Med. 2017;14:3477-3484.
    >> Share

    Expert Opin Pharmacother

  11. CARAMES MASANA F, de Reijke TM
    The efficacy of Apaziquone in the treatment of bladder cancer.
    Expert Opin Pharmacother. 2017 Oct 20:1-8. doi: 10.1080/14656566.2017.1392510.
    >> Share

    Hum Exp Toxicol

  12. VERMA H, Sharma T, Gupta S, Banerjee BD, et al
    CYP1A1 expression and organochlorine pesticides level in the etiology of bladder cancer in North Indian population.
    Hum Exp Toxicol. 2017 Jan 1:960327117734623. doi: 10.1177/0960327117734623.
    >> Share

    Hum Pathol

  13. WANG G, Huang H, Kamat AM, Siefker-Radtke A, et al
    High-grade neuroendocrine carcinoma of the urachus-report of 3 cases.
    Hum Pathol. 2017;67:126-133.
    >> Share

  14. URREA YR, Epstein JI
    Sarcomatoid carcinoma associated with small cell carcinoma of the urinary bladder: a series of 28 cases.
    Hum Pathol. 2017;67:169-175.
    >> Share

  15. GIANNICO GA, Gown AM, Epstein JI, Revetta F, et al
    Role of SATB2 in distinguishing the site of origin in glandular lesions of the bladder/urinary tract.
    Hum Pathol. 2017;67:152-159.
    >> Share


  16. SEEGOBIN K, Maharaj S, Baldeo C, Isache C, et al
    Mycobacteria Bovis osteomyelitis following intravesical BCG for bladder cancer.
    IDCases. 2017;10:75-78.
    >> Share

    Int J Med Robot

  17. TANG JQ, Zhao Z, Liang Y, Liao G, et al
    Robotic-assisted versus open radical cystectomy in bladder cancer: A meta-analysis of four randomized controlled trails.
    Int J Med Robot. 2017 Oct 12. doi: 10.1002/rcs.1867.
    >> Share

    Int J Mol Sci

  18. MIYAKE M, Tatsumi Y, Gotoh D, Ohnishi S, et al
    Regulatory T Cells and Tumor-Associated Macrophages in the Tumor Microenvironment in Non-Muscle Invasive Bladder Cancer Treated with Intravesical Bacille Calmette-Guerin: A Long-Term Follow-Up Study of a Japanese Cohort.
    Int J Mol Sci. 2017;18.
    >> Share

    Int Urol Nephrol

  19. YAMASHITA R, Watanabe R, Ito I, Shinsaka H, et al
    Risk factors for intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
    Int Urol Nephrol. 2017;49:425-430.
    >> Share

    J Natl Compr Canc Netw

  20. DELL'OGLIO P, Tian Z, Leyh-Bannurah SR, Trudeau V, et al
    Short-Form Charlson Comorbidity Index for Assessment of Perioperative Mortality After Radical Cystectomy.
    J Natl Compr Canc Netw. 2017;15:327-333.
    >> Share

    J Urol

  21. RYAN S, Serrell EC, Karabon P, Mills G, et al
    The Association Between Mortality and Distance to Treatment Facility in Patients with Muscle Invasive Bladder Cancer.
    J Urol. 2017 Oct 10. pii: S0022-5347(17)77715-4. doi: 10.1016/j.juro.2017.
    >> Share


  22. WALLIS CJD, Juvet T, Lee Y, Matta R, et al
    Association Between Use of Antithrombotic Medication and Hematuria-Related Complications.
    JAMA. 2017;318:1260-1271.
    >> Share



    Lakartidningen. 2017;114.
    >> Share

    Medicine (Baltimore)

  24. QUAN Y, Jeong CW, Kwak C, Kim HH, et al
    Dose, duration and strain of bacillus Calmette-Guerin in the treatment of nonmuscle invasive bladder cancer: Meta-analysis of randomized clinical trials.
    Medicine (Baltimore). 2017;96:e8300.
    >> Share

    Oncol Rep

  25. HUANG B, Zhang J, Zhang X, Huang C, et al
    Suppression of LETM1 by siRNA inhibits cell proliferation and invasion of bladder cancer cells.
    Oncol Rep. 2017 Sep 18. doi: 10.3892/or.2017.5959.
    >> Share

  26. KOU B, Liu W, Xu X, Yang Y, et al
    Autophagy induction enhances tetrandrine-induced apoptosis via the AMPK/mTOR pathway in human bladder cancer cells.
    Oncol Rep. 2017 Sep 21. doi: 10.3892/or.2017.5988.
    >> Share

  27. ZHAO X, Ji Z, Xie Y, Liu G, et al
    MicroRNA-154 as a prognostic factor in bladder cancer inhibits cellular malignancy by targeting RSF1 and RUNX2.
    Oncol Rep. 2017 Sep 25. doi: 10.3892/or.2017.5992.
    >> Share


  28. XU L, Li H, Wu L, Huang S, et al
    YBX1 promotes tumor growth by elevating glycolysis in human bladder cancer.
    Oncotarget. 2017;8:65946-65956.
    >> Share

  29. YUAN L, Shu B, Chen L, Qian K, et al
    Overexpression of COL3A1 confers a poor prognosis in human bladder cancer identified by co-expression analysis.
    Oncotarget. 2017;8:70508-70520.
    >> Share

  30. LATOSINSKA A, Mokou M, Makridakis M, Mullen W, et al
    Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention.
    Oncotarget. 2017;8:69435-69455.
    >> Share

  31. REN R, Tyryshkin K, Graham CH, Koti M, et al
    Comprehensive immune transcriptomic analysis in bladder cancer reveals subtype specific immune gene expression patterns of prognostic relevance.
    Oncotarget. 2017;8:70982-71001.
    >> Share

  32. LI Y, Lin K, Yang Z, Han N, et al
    Bladder cancer stem cells: clonal origin and therapeutic perspectives.
    Oncotarget. 2017;8:66668-66679.
    >> Share

  33. WANG X, Xu T, Gao F, He H, et al
    Targeting of CCN2 suppresses tumor progression and improves chemo-sensitivity in urothelial bladder cancer.
    Oncotarget. 2017;8:66316-66327.
    >> Share

  34. KUSAKA A, Hatakeyama S, Hosogoe S, Hamano I, et al
    Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer.
    Oncotarget. 2017;8:65492-65505.
    >> Share

  35. POLO A, Crispo A, Cerino P, Falzone L, et al
    Environment and bladder cancer: molecular analysis by interaction networks.
    Oncotarget. 2017;8:65240-65252.
    >> Share

    PLoS One

  36. DAI YC, Wang SC, Haque MM, Lin WH, et al
    The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice.
    PLoS One. 2017;12:e0186214.
    >> Share

  37. HUANG JY, Wang R, Gao YT, Yuan JM, et al
    ABO blood type and the risk of cancer - Findings from the Shanghai Cohort Study.
    PLoS One. 2017;12:e0184295.
    >> Share

  38. KWAK YK, Lee SW, Kay CS, Park HH, et al
    Intensity-modulated radiotherapy reduces gastrointestinal toxicity in pelvic radiation therapy with moderate dose.
    PLoS One. 2017;12:e0183339.
    >> Share

    Res Rep Urol

  39. HOLZ S, Albisinni S, Gilsoul J, Pirson M, et al
    Risk factor assessment in high-risk, bacillus Calmette-Guerin-treated, non-muscle-invasive bladder cancer.
    Res Rep Urol. 2017;9:195-202.
    >> Share

    World J Urol

  40. PACKIAM VT, Agrawal VA, Pariser JJ, Cohen AJ, et al
    Redefining the implications of nasogastric tube placement following radical cystectomy in the alvimopan era.
    World J Urol. 2017;35:625-631.
    >> Share

  41. SHARMA P, Zargar-Shoshtari K, Poch MA, Pow-Sang JM, et al
    Surgical control and margin status after robotic and open cystectomy in high-risk cases: Caution or equivalence?
    World J Urol. 2017;35:657-663.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016